story of the week
Neoadjuvant Nivolumab vs Nivolumab Plus Ipilimumab for Early-Stage TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial
Nat. Med. 2024 Sep 16;[EPub Ahead of Print], I Nederlof, OI Isaeva, M de Graaf, RCAM Gielen, NAM Bakker, AL Rolfes, H Garner, B Boeckx, JJH Traets, IAM Mandjes, M de Maaker, T van Brussel, M Chelushkin, E Champanhet, M Lopez-Yurda, K van de Vijver, JG van den Berg, I Hofland, N Klioueva, RM Mann, CE Loo, FH van Duijnhoven, V Skinner, S Luykx, E Kerver, E Kalashnikova, MGJ van Dongen, GS Sonke, SC Linn, CU Blank, KE de Visser, R Salgado, LFA Wessels, CA Drukker, TN Schumacher, HM Horlings, D Lambrechts, M KokFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.